Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Macro-Group-Pharmaceutical is a pioneering global biopharmaceutical company committed to the discovery, development, manufacturing, and commercialization of innovative therapies for unmet medical needs. With a strong focus on scientific excellence and patient outcomes, we strive to address some of the world's most challenging diseases across various therapeutic areas including oncology, immunology, neuroscience, and rare diseases. Our integrated approach, from cutting-edge research in our state-of-the-art laboratories to ensuring worldwide access to our medicines, defines our dedication to advancing global health.
The Basel headquarters serves as the central hub for global strategy, corporate governance, research and development leadership, and international commercial operations.
The campus features state-of-the-art research laboratories, collaborative workspaces designed for innovation, and environmentally sustainable architecture.
The work culture at the Basel HQ is dynamic and collaborative, fostering scientific curiosity, cross-functional teamwork, and a strong commitment to ethical practices and patient well-being.
Its location in Basel provides access to a rich ecosystem of academic institutions, biotech partners, and a highly skilled talent pool, reinforcing its position as a global leader in pharmaceuticals.
Macro-Group-Pharmaceutical supports a wide range of functions globally, including cutting-edge Research & Development (R&D) in multiple specialized centers, GMP-compliant Manufacturing and Supply Chain operations across continents, comprehensive Clinical Trial Management in numerous countries, and robust Commercial Operations including sales, marketing, and market access teams tailored to local healthcare systems worldwide.
Innovationspark 1, CH-4056
Basel
Basel-Stadt
Switzerland
Address: Biotech Row 500, Cambridge, MA 02142, USA
To drive innovation in key therapeutic areas, particularly in gene therapy and biologics, and to manage clinical trials and commercial activities across North America.
Address: Pharma Valley Park, Building 3, Pudong, Shanghai, 201203, China
To expand access to innovative medicines in the fast-growing APAC region, conduct locally relevant clinical research, and build strategic collaborations.
Address: Europa-Allee 22, 60327 Frankfurt am Main, Germany
To ensure efficient supply chain management and market access for Macro-Group-Pharmaceutical products throughout Europe, and to engage with European regulatory bodies.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, MACRO GROUP Pharmaceuticals' leadership includes:
MACRO GROUP Pharmaceuticals has been backed by several prominent investors over the years, including:
Over the past year, Macro-Group-Pharmaceutical has seen strategic movements within its executive team, including the appointment of a new Chief Financial Officer to steer financial strategy and growth, and the retirement of a long-serving executive.
Discover the tools MACRO GROUP Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Macro-Group-Pharmaceutical primarily utilizes standard corporate email formats, typically combining the employee's first initial and last name, or first name and last name separated by a dot, followed by the company domain.
[first_initial][last]@macro-group-pharmaceutical.com OR [first].[last]@macro-group-pharmaceutical.com
Format
evance@macro-group-pharmaceutical.com or eleanor.vance@macro-group-pharmaceutical.com
Example
95%
Success rate
Global Pharma Wire • March 12, 2024
Macro-Group-Pharmaceutical today reported highly encouraging top-line results from its pivotal Phase 3 clinical trial for OncoVance, a first-in-class therapy for treatment-resistant lung cancer. The study met its primary endpoint, demonstrating significant improvement in overall survival....more
BioCentury Today • February 20, 2024
Macro-Group-Pharmaceutical and NeuroGen Innovations have announced a multi-year collaboration to co-develop novel diagnostic tools and therapeutic candidates for Alzheimer's disease, combining Macro-Group's development expertise with NeuroGen's cutting-edge research platform....more
Pharma Manufacturing News • January 15, 2024
Macro-Group-Pharmaceutical has officially inaugurated its new biologics manufacturing plant in Dublin, Ireland. The facility will significantly expand the company's capacity for producing next-generation antibody therapies and create hundreds of skilled jobs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including MACRO GROUP Pharmaceuticals, are just a search away.